Longitudinal association between visceral adiposity index and arthritis-diabetes comorbidity risk: A cohort study

Huidong Zhang1,2, Hanyi Wang2, Xinyi Zhang2

  • 1Hebei University of Chinese Medicine, Graduate School, Shijiazhuang, Hebei Province, China.

Medicine
|July 31, 2026
PubMed

Insights

Visceral adiposity index (VAI) can predict the risk of developing arthritis and diabetes comorbidity in older Chinese adults. Higher VAI levels are associated with increased risk, suggesting VAI as a potential noninvasive screening tool.

Area of Science:

  • Metabolic Health
  • Chronic Disease Epidemiology
  • Biomarker Research

Background:

  • Visceral adiposity is linked to chronic inflammation and disease.
  • The predictive value of the visceral adiposity index (VAI) for arthritis-diabetes comorbidity is not well-established.
  • Noninvasive markers for predicting chronic disease risk are needed.

Purpose of the Study:

  • To investigate the association between VAI and the risk of developing arthritis-diabetes comorbidity.
  • To evaluate VAI as a potential noninvasive tool for risk prediction.
  • To explore dose-response relationships and subgroup effects.

Main Methods:

  • Utilized data from the China Health and Retirement Longitudinal Survey (CHARLS) of adults aged 45 and above.
  • Employed multivariate logistic regression analyses, adjusting for confounders.
  • Assessed predictive power using receiver-operating characteristic (ROC) curves and analyzed subgroup effects.

Main Results:

  • A positive correlation was observed between VAI and arthritis-diabetes comorbidity.
  • Each interquartile range increase in VAI was associated with a 10% increased risk (OR=1.10).
  • Individuals in the highest VAI quartile had a significantly higher risk (OR=4.30) compared to the lowest, with a significant dose-response trend (P=0.001).
  • The fully adjusted model showed moderate discriminative ability (AUC=0.703).
  • Consistent associations were found in females and non-smokers, with a nonlinear dose-response relationship.

Conclusions:

  • Increased VAI is an independent predictor of higher arthritis-diabetes comorbidity risk in middle-aged/elderly Chinese adults.
  • The association exhibits nonlinearity and subgroup heterogeneity.
  • Targeted visceral adiposity reduction in high-risk groups may be a viable strategy for chronic disease prevention.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...